UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs

Arteriosclerosis, thrombosis, and vascular biology, 2008-03, Vol.28 (3), p.413-418

2008

Volltextzugriff (PDF)

Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis

Thrombosis and haemostasis, 2008-04, Vol.99 (4), p.759-766

2008

Volltextzugriff (PDF)

Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action

Bioorganic & medicinal chemistry, 2009-03, Vol.17 (6), p.2501-2511

2009

Volltextzugriff (PDF)

Structure-based Drug Design of Pyrrolidine-1, 2-dicarboxamides as a Novel Series of Orally Bioavailable Factor Xa Inhibitors

Chemical biology & drug design, 2007-06, Vol.69 (6), p.444-450

2007

Volltextzugriff (PDF)

Co-crystal Structure and Inhibition of Factor Xa by PD0313052 Identifies Structurally Stabilized Active Site Residues of Factor Xa and Prothrombinase

Biochemistry (Easton), 2005-07, Vol.44 (26), p.9280-9289

2005

Volltextzugriff (PDF)

Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

British journal of pharmacology, 2001-08, Vol.133 (7), p.1190-1198

2001

Volltextzugriff (PDF)

Coagulation factor Xa inhibition: biological background and rationale

Current topics in medicinal chemistry, 2001-06, Vol.1 (2), p.151-159

Leadley, Jr, R J

2001

Volltextzugriff (PDF)

Inhibition of repetitive thrombus formation in the stenosed canine coronary artery by enoxaparin, but not by unfractionated heparin

Arteriosclerosis, thrombosis, and vascular biology, 1998-06, Vol.18 (6), p.908-914

1998

Volltextzugriff (PDF)

The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor

Chemical biology & drug design, 2007-08, Vol.70 (2), p.100-112

2007

Volltextzugriff (PDF)

In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737

Thrombosis research, 2000-07, Vol.99 (1), p.71-82

2000

Volltextzugriff (PDF)

Development and applications of animal models of thrombosis

Methods in molecular medicine, 2004, Vol.93, p.175

2004

Volltextzugriff (PDF)

Cloning and characterization of a novel regulator of G protein signalling in human platelets

Cellular signalling, 2002-07, Vol.14 (7), p.595-606

2002

Volltextzugriff (PDF)

Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents

Journal of pharmacological and toxicological methods, 2000-03, Vol.43 (2), p.101-116

2000

Volltextzugriff (PDF)

Non-hemostatic activity of coagulation factor Xa: potential implications for various diseases

Current Opinion in Pharmacology, 2001-04, Vol.1 (2), p.169-175

2001

Volltextzugriff (PDF)

The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2

Bioorganic & medicinal chemistry letters, 2006-02, Vol.16 (4), p.1060-1064

2006

Volltextzugriff (PDF)

Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity

Bioorganic & medicinal chemistry letters, 2002-06, Vol.12 (12), p.1671-1674

2002

Volltextzugriff (PDF)

The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex

Bioorganic & medicinal chemistry letters, 2005-11, Vol.15 (21), p.4752-4756

2005

Volltextzugriff (PDF)

Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa

Journal of medicinal chemistry, 1998-02, Vol.41 (4), p.437-450

1998

Volltextzugriff (PDF)

RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit

Thrombosis and haemostasis, 1999-01, Vol.81 (1), p.157-160

1999

Volltextzugriff (PDF)

Optimization of the β-aminoester class of factor Xa inhibitors. Part 1: P4 and side-chain modifications for improved in vitro potency

Bioorganic & medicinal chemistry letters, 2002-06, Vol.12 (12), p.1667-1670

2002

Volltextzugriff (PDF)

Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs

Journal of cardiovascular pharmacology, 2001-08, Vol.38 (2), p.288-297

2001

Volltextzugriff (PDF)

Design of a New Class of Orally Active Fibrinogen Receptor Antagonists

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2492-2502

1998

Volltextzugriff (PDF)

Recent advances in the discovery and development of direct coagulation factor Xa inhibitors

Current pharmaceutical design, 2003-01, Vol.9 (28), p.2337-2347

2003

Volltextzugriff (PDF)

Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa

Journal of cardiovascular pharmacology, 1999-12, Vol.34 (6), p.791-799

1999

Volltextzugriff (PDF)

Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery

Thrombosis and haemostasis, 1997-10, Vol.78 (4), p.1278-1285

1997

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(59)
Animals
(41)
Biological And Medical Sciences
(41)
Medical Sciences
(32)
Humans
(29)
Pharmacology. Drug Treatments
(28)
Factor Xa Inhibitors
(27)
Pharmacology & Pharmacy
(27)
Blood. Blood Coagulation. Reticuloendothelial System
(26)
Dogs
(26)
Cardiovascular System & Cardiology
(19)
Female
(17)
Chemistry, Medicinal
(16)
Peripheral Vascular Disease
(13)
Fibrinolytic Agents - Pharmacology
(12)
Hematology
(12)
Physical Sciences
(12)
Disease Models, Animal
(11)
Male
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs

Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis

Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action

Structure-based Drug Design of Pyrrolidine-1, 2-dicarboxamides as a Novel Series of Orally Bioavailable Factor Xa Inhibitors

Co-crystal Structure and Inhibition of Factor Xa by PD0313052 Identifies Structurally Stabilized Active Site Residues of Factor Xa and Prothrombinase

Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis

Coagulation factor Xa inhibition: biological background and rationale

Inhibition of repetitive thrombus formation in the stenosed canine coronary artery by enoxaparin, but not by unfractionated heparin

The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor

In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737

Development and applications of animal models of thrombosis

Cloning and characterization of a novel regulator of G protein signalling in human platelets

Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents

Non-hemostatic activity of coagulation factor Xa: potential implications for various diseases

The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2

Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity

The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex

Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa

RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit

Optimization of the β-aminoester class of factor Xa inhibitors. Part 1: P4 and side-chain modifications for improved in vitro potency

Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs

Design of a New Class of Orally Active Fibrinogen Receptor Antagonists

Recent advances in the discovery and development of direct coagulation factor Xa inhibitors

Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa

Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery

Suchergebnisse filtern